Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil

Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues...

Full description

Saved in:
Bibliographic Details
Published inBoletin medico del Hospital Infantil de Mexico Vol. 81; no. Supl 2; p. 1
Main Authors Toledo-Bahena, Mirna E, Camargo-Sánchez, Karen A, Cruz, Helena Vidaurri-De la, Valencia-Herrera, Adriana M, Ocáriz, M Mar Sáez-de, Duarte-Abdala, Mario R, Osuna-Osuna, Julieta, Aranda-Mendoza, Jessica, Rosales-Solís, Gloria M, Maza-Ramos, Gibert, Orozco-Covarrubias, M Luz, Valle, Pablo Lezama-Del, Erdmenger-Orellana, Julio R, Enríquez-García, Rocío, Dies-Suárez, Pilar, Celis-Jiménez, Alejandro, Mena-Cedillos, Carlos A
Format Journal Article
LanguageEnglish
Published Mexico 2024
Subjects
Follow-Up Studies
Hemangioma - diagnosis
Hemangioma - therapy
Humans
Infant
Mexico
Practice Guidelines as Topic
Quality of Life
Mexico
Vascular tumor
Tumor vascular
GLUT-1
Vascular anomaly
Anomalía vascular
Infantile hemangioma
Hemangioma infantil
Propranolol
Timolol
Online AccessGet more information

Cover

More Information
Summary:Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.
ISSN:1665-1146